Mercer Capital Advisers’s Novartis NVS Stock Holding History

Mercer Capital Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$380K	Sell	4,650 -200	-4%	-$18K	0.2%	68
2021 Q2	$443K	Hold	4,850	–	–	0.22%	67
2021 Q1	$416K	Hold	4,850	–	–	0.22%	65
2020 Q4	$458K	Hold	4,850	–	–	0.25%	57
2020 Q3	$422K	Hold	4,850	–	–	0.26%	56
2020 Q2	$424K	Buy	4,850 +500	+11%	+$43.2K	0.27%	55
2020 Q1	$359K	Sell	4,350 -600	-12%	-$53.5K	0.27%	54
2019 Q4	$469K	Hold	4,950	–	–	0.28%	58
2019 Q3	$430K	Hold	4,950	–	–	0.27%	58
2019 Q2	$452K	Sell	4,950 -574	-10%	-$48.6K	0.29%	56
2019 Q1	$476K	Sell	5,524 -112	-2%	-$8.99K	0.32%	53
2018 Q4	$433K	Hold	5,636	–	–	0.32%	56
2018 Q3	$435K	Hold	5,636	–	–	0.29%	60
2018 Q2	$381K	Hold	5,636	–	–	0.28%	59
2018 Q1	$408K	Hold	5,636	–	–	0.3%	59
2017 Q4	$424K	Sell	5,636 -602	-10%	-$45.4K	0.31%	57
2017 Q3	$480K	Hold	6,238	–	–	0.36%	54
2017 Q2	$467K	Hold	6,238	–	–	0.35%	55
2017 Q1	$415K	Hold	6,238	–	–	0.32%	56
2016 Q4	$407K	Sell	6,238 -558	-8%	-$36.2K	0.33%	57
2016 Q3	$481K	Hold	6,796	–	–	0.39%	50
2016 Q2	$502K	Hold	6,796	–	–	0.41%	48
2016 Q1	$441K	Buy	6,796 +223	+3%	+$15.2K	0.38%	53
2015 Q4	$507K	Hold	6,573	–	–	0.45%	43
2015 Q3	$541K	Hold	6,573	–	–	0.5%	42
2015 Q2	$579K	Hold	6,573	–	–	0.52%	37
2015 Q1	$581K	Sell	6,573 -112	-2%	-$9.93K	0.52%	37
2014 Q4	$555K	Buy	+6,685	New	+$554K	0.49%	39

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Mercer Capital Advisers's NVS Position: Q3 2021 in Review

Mercer Capital Advisers reduced its Novartis (NVS) stake by 4.1% in Q3 2021, selling an estimated $18K and leaving 4,650 shares worth $380K. The position accounts for 0.2% of the portfolio, ranked #68.

Mercer Capital Advisers first reported a position in NVS in Q4 2014 and has held it in 28 quarters since. The position peaked at $581K in Q1 2015. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

Mercer Capital Advisers held 4,650 shares of Novartis worth $380K as of Q3 2021.
Mercer Capital Advisers sold 200 Novartis shares in Q3 2021, an estimated $18K.
Novartis made up 0.2% of Mercer Capital Advisers's portfolio in Q3 2021, its #68 holding.
Mercer Capital Advisers first reported a position in Novartis in Q4 2014 and has held it in 28 quarters since.
Mercer Capital Advisers's Novartis position peaked at $581K in Q1 2015.
1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Mercer Capital Advisers's 13F filing for Q3 2021, filed 27 Oct 2021.